(redirected from portal hypertension)
Also found in: Dictionary, Thesaurus, Medical, Financial, Encyclopedia, Wikipedia.
Related to portal hypertension: ascites
References in periodicals archive ?
Scope of the report : The report provides a snapshot of the global therapeutic landscape of Portal Hypertension and reviews key players involved in the therapeutics development for Portal Hypertension and enlists all their major and minor projects summarizing all the dormant and discontinued pipeline projects.
The study of 100 patients with hepatitis C and compensated cirrhosis showed that the probability of developing a first episode of liver decompensation at 1, 5, and 7 years was 4%, 25%, and 28%, respectively, among patients with an hepatic venous pressure gradient (HVPG) value of 10 mm Hg or above, compared with 0, 0, and 16% in patients without cirrhosis with severe portal hypertension (CSPH).
The former is most likely if they have stigmata of chronic liver disease and portal hypertension and the latter assumed in the absence of these findings.
Portal hypertension and related splenomegaly and reserving of the platalets in the spleen is the most important reason for thrombocytopenia (21).
16) In a study of Italian patients with NASH, (4) portal hypertension appeared to only occur in patients having established cirrhosis.
GlobalData's clinical trial report, Portal Hypertension Global Clinical Trials Review, H1, 2013" provides data on the Portal Hypertension clinical trial scenario.
The degree of portal hypertension at the time of the procedure is correlated with a shorter time to requiring liver transplantation, reflecting liver pathophysiology in a more functional way.
CHF is an inherited disease that affects both liver and kidneys and it could cause scarring and hardening of the liver, which makes it more difficult for the blood to flow through it thus causing a condition called portal hypertension, where there is increased pressure in the veins that carry blood to the liver.
It provides a valuable forum for teaching intricate operative technique, collateralized vascular anatomy, and the pathophysiology of PH-plus it is highly efficacious in treating appropriate patients with portal hypertension.
The actuality of this research is caused by significant growth of the incidence of portal hypertension in patients with diffuse chronic liver disease in recent years [1-5].
I have been diagnosed with chronic liver disease and I have portal hypertension.
Historically, aneurysms have been mycotic, syphilitic, or traumatic in origin but are now more likely related to essential or portal hypertension (2, 3).